← Leaderboards
Changwei Li
Tulane University Of Louisiana
$1,910,072
Attributed
$2,425,860
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $988.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,425,860 · 3
By mechanism
R01$1,416,815 · 1
P20$765,031 · 1
R21$244,014 · 1
Top collaborators
- Dan E Arking1 shared
- Tanika Nicole Kelly1 shared
- Wei Yang1 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Wei Chen$6,318,287
- Gerald S Berenson$12,012,112
- Lydia Bazzano$16,911,507
- Paul Muntner$9,260,804
- Emily Wheeler Harville$9,394,546
Others in their field
Other Rising Stars on “Molecular”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
MolecularMediatingFollow-UpParticipantInnovationLinkPreventCohortPublic HealthProgramsKidneyChronic Kidney InsufficiencyClinically SignificantMetabolomeHigh RiskGenomic DataMediationBlack RaceEvidence BaseEventDisease ProgressionBiologicalEnd Stage Renal FailureCohort Studies
Grant awards (7)
The quality and quantity of mitochondrial DNA in chronic kidney disease progression$687,717
R01 · FY2025 · DK · contact PI
The quality and quantity of mitochondrial DNA in chronic kidney disease progression$729,098
R01 · FY2024 · DK · contact PI
Metabolomics Study of APOL1-Associated Chronic Kidney Disease Progression$258,979
P20 · FY2024 · GM · contact PI
Metabolomics Study of APOL1-Associated Chronic Kidney Disease Progression$251,762
P20 · FY2023 · GM · contact PI
Application of a novel polygenic risk score to the study of diabetic cardiomyopathy in diverse populations$122,007
R21 · FY2023 · HL · contact PI
Metabolomics Study of APOL1-Associated Chronic Kidney Disease Progression$254,290
P20 · FY2022 · GM · contact PI
Application of a novel polygenic risk score to the study of diabetic cardiomyopathy in diverse populations$122,007
R21 · FY2022 · HL · contact PI